(Q36666317)

15 August 2017

1 reference

title

Vitamin D replacement for cirrhosis-related bone disease (English)

1 reference

15 August 2017

0 references

4

Geoffrey W McCaughan

1 reference

15 August 2017

Bronwyn A Crawford

1

1 reference

15 August 2017

Eternity D Labio

series ordinal

2

1 reference

15 August 2017

Simone I Strasser

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Nature Reviews Gastroenterology & Hepatology

15 August 2017

published in

1 reference

15 August 2017

volume

3

1 reference

15 August 2017

issue

12

1 reference

15 August 2017

page(s)

689-699

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpgasthep0637

15 August 2017

exact match

0 references

cites work

AGA technical review on osteoporosis in hepatic disorders.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Guidelines on the management of osteoporosis associated with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

The heterogeneity of bone disease in cirrhosis: a multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Osteoporosis in chronic liver disease: pathogenesis, risk factors, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Bone disease in cholestatic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

21 January 2018

Hepatic osteodystrophy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Osteoporosis in liver diseases and after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Metabolism and Excretion of3H-1,2 5-(OH)2-Vitamin D3in Healthy Adults*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Plasma vitamin D-binding globulin in vitamin D deficiency, pregnancy and chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Abnormal vitamin D metabolism in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

The multifunctional properties and characteristics of vitamin D-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

25-Hydroxylation of vitamin D in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Hepatic handling of vitamin D3 in micronodular cirrhosis: a structure-function study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

The physiological economy of vitamin D

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

21 January 2018

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Enterohepatic circulation of vitamin D: a reappraisal of the hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

A new mechanism for induced vitamin D deficiency in calcium deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Evidence for secondary hyperparathyroidism in the osteomalacia associated with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Calcitriol for bone disease in patients with cirrhosis of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Prevalence and prediction of osteopenia in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

L-amino acid sensing by the extracellular Ca2+-sensing receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

High Prevalence of Vitamin D Inadequacy and Implications for Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

The role of vitamin D in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Vitamin D and muscle function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Vitamin D: more than just affecting calcium and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Management of chronic hepatitis C virus infection: a new era of disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Vitamin D2 is much less effective than vitamin D3 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

25-Hydroxylase activity in subcellular fractions from human liver. Evidence for different rates of mitochondrial hydroxylation of vitamin D2 and D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

How to prevent steroid induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Use of oral corticosteroids and risk of fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

American Gastroenterological Association medical position statement: osteoporosis in hepatic disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Estimates of beneficial and harmful sun exposure times during the year for major Australian population centres.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Editorial: The determination of circulating 25-hydroxyvitamin D: no easy task

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Concentrations of vitamin D-binding protein and vitamin D metabolites in plasma of patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Hepatic osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Vitamin D deficiency, osteomalacia, and primary biliary cirrhosis. Response to orally administered vitamin D3

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Severe cholestasis leads to vitamin D depletion without perturbing its C-25 hydroxylation in the dog

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

1 reference

7 January 2021

The biliary excretion of (3H)-25-hydroxyvitamin D3 following chronic ethanol administration in the rat

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis?

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Vitamin D prophylaxis and osteomalacia in chronic cholestatic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Metabolic bone disease in alcoholic cirrhosis: a comparison of the effect of vitamin D2, 25-hydroxyvitamin D, or supportive treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Treatment of postmenopausal osteoporosis with calcitriol or calcium

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Amount and composition of bone minerals in chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Serum Parathyroid Hormone Is Associated with Increased Mortality Independent of 25-Hydroxy Vitamin D Status, Bone Mass, and Renal Function in the Frail and Very Old: A Cohort Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Secondary hyperparathyroidism in the elderly: means to defining hypovitaminosis D.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Vitamin D supplementation and bone mineral density in early postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2.

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Seizures after alendronate

1 reference

https://api.crossref.org/works/10.1038%2FNCPGASTHEP0637

7 January 2021

Identifiers

DOI

10.1038/NCPGASTHEP0637

1 reference

15 August 2017

1 reference